Stock PHGE.U BIOMX INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar BiomX Inc. Nyse

Equities

PHGE.U

US09090D2027

Delayed Nyse
Other stock markets
 21:15:01 05/07/2024 BST 		5-day change 1st Jan Change
0.4 USD 0.00% Intraday chart for BiomX Inc. 0.00% +58.73%
05-21 Transcript : BiomX Inc., Q1 2024 Earnings Call, May 21, 2024
05-20 BiomX Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Chart calendar BiomX Inc.

97a.IjJWd13L70umIvU8A-cU7ANUtzdA2PWWh9--wMjfEUQ.ZUobJAKSnCbxSrpIRLBgp1E8hHourJbPt4_sl6S0cghgQ24lNf-sfpZVzQ~4589982500b706deb05f8ca6a0e5d6de

Upcoming events on BiomX Inc.

09/07/2024 13:00 Annual General Meeting
13/08/2024 Q2 2024 Earnings Release (Projected)
12/11/2024 Q3 2024 Earnings Release (Projected)
25/03/2025 Q4 2024 Earnings Release (Projected)
13/05/2025 Q1 2025 Earnings Release (Projected)

Past events on BiomX Inc.

14/06/2024 16:45 American Society for Microbiology Microbe Meeting - Abstract No: 6480
14/06/2024 15:30 American Society for Microbiology Microbe Meeting
06/06/2024 18:15 European Cystic Fibrosis Conference - Abstract No: WS06.06
21/05/2024 13:00 Q1 2024 Earnings Call
21/05/2024 11:30 Q1 2024 Earnings Release
15/05/2024 21:05 RBC Capital Markets Global Healthcare Conference
28/04/2024 11:00 ECCMID Meeting - Poster No - P2546
03/04/2024 13:00 Q4 2023 Earnings Call
03/04/2024 11:30 Q4 2023 Earnings Release
06/03/2024 14:00 Acquisition of Adaptive Phage Therapeutics, Inc. by BiomX, Inc. Call
04/12/2023 17:00 Investor Meeting - Key Opinion Leader
29/11/2023 14:00 BX004 Phase 2b/3 Study Results Call
14/11/2023 11:30 Q3 2023 Earnings Release
03/11/2023 15:30 North American Cystic Fibrosis Conference
11/09/2023 12:00 H.C. Wainwright Global Investment Conference
10/09/2023 14:45 European Respiratory Society International Congress - Abstract No: OA1534
28/08/2023 13:00 Extraordinary Shareholders Meeting
09/08/2023 13:00 Q2 2023 Earnings Call
09/08/2023 11:30 Q2 2023 Earnings Release
20/06/2023 13:00 Annual General Meeting

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,75
- 		0,00
0,00
- 		0,00
0,00
-
0,00

EBITDA
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		-28,1
-30,1
6.72%		-32,9
-32,9
0.01%		-25,7
-27,4
6.2%		-25,3
-28,0
9.47%
-33,4

EBIT
Million USD		Released
Forecast
Spread 		-22,2
-17,0
-30.63%		-30,3
-29,6
-2.4%		-35,5
-32,5
-9.06%		-27,2
-27,3
0.25%		-25,3
-26,8
5.4%
-30,5

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-20,6
-16,0
-28.52%		-30,1
-29,4
-2.33%		-36,2
-33,3
-8.66%		-28,3
-29,1
2.98%		-26,1
-27,6
5.12%
-44,1

Net income
Million USD		Released
Forecast
Spread 		-20,6
-16,0
-28.75%		-30,1
-29,4
-2.38%		-36,2
-33,3
-8.73%		-28,3
-29,1
2.76%		-26,2
-27,6
5.21%
-44,1

EPS
USD		Released
Forecast
Spread 		-3,66
-0,20
-1730%		-1,30
-1,26
-2.9%		-1,39
-1,30
-6.92%		-0,95
-0,98
2.56%		-0,51
-0,54
5.56%
-0,49

Announcement Date26/03/2031/03/2130/03/2229/03/2303/04/24-

Quarterly results

Fiscal PeriodDecember 2021 S1 2022 Q1 2022 Q2 2022 S1 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
- 		0,00
0,00
-
0,00


0,00


0,00


0,00


0,00


0,00

EBITDA
Million USD		Released
Forecast
Spread 		-14,7
-17,3
14.9%		-7,15
-9,40
23.89%		-6,69
-8,50
21.31%		-13,8
-16,3
15.07%		-6,17
-7,00
11.87%		-5,18
-6,90
24.93%		-6,21
-5,50
-12.87%		-5,86
-6,30
7.05%		-7,58
-5,90
-28.41%		-5,27
-8,00
34.1%		-6,79
-6,60
-2.8%
-7,70


-14,5


-8,70


-10,2







EBIT
Million USD		Released
Forecast
Spread 		-15,8
-17,3
8.42%		-7,79
-8,34
6.69%		-7,32
-7,55
2.94%


-6,55
-6,32
-3.66%		-5,56
-6,55
15.11%		-6,21
-5,63
-10.31%		-6,07
-6,34
4.26%		-7,80
-5,91
-31.85%		-5,27
-5,51
4.37%		-6,79
-9,57
29.08%
-7,06





-7,43


-7,81


-7,74


-8,39

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		-15,7
-17,5
10.1%		-8,16
-9,07
10.08%		-7,47
-8,32
10.15%		-15,6
-17,0
8.04%		-6,77
-7,04
3.75%		-5,85
-7,06
17.2%		-6,36
-5,91
-7.47%		-6,40
-6,59
2.79%		-7,90
-6,28
-25.79%		-5,49
-6,93
20.77%		-17,3
-8,31
-108.51%
-8,31


-25,4


-8,86


-9,58


-10,3


-11,0

Net income
Million USD		Released
Forecast
Spread 		-15,7
-17,5
10.07%		-8,17
-9,07
9.98%		-7,48
-8,32
10.04%		-15,7
-17,0
7.94%		-6,78
-7,04
3.63%		-5,89
-7,06
16.65%		-6,36
-5,90
-7.84%		-6,41
-6,64
3.5%		-7,91
-6,28
-25.92%		-5,49
-6,93
20.76%		-17,3
-8,31
-108.57%
-8,31


-25,4


-8,87


-9,61


-10,3


-11,0

EPS
USD		Released
Forecast
Spread 		-0,65
-0,72
9.72%		-0,27
-0,30
10.99%		-0,25
-0,27
7.41%		-0,53
-0,57
7.02%		-0,23
-0,23
-1.1%		-0,20
-0,23
13.04%		-0,20
-0,18
-14.29%		-0,12
-0,15
17.24%		-0,13
-0,10
-30%		-0,08
-0,11
27.27%		-0,28
-0,12
-143.48%
-0,09


-0,38


-0,09


-0,10


-0,05


-0,05

Announcement Date16/08/2111/05/2210/08/2210/08/2209/11/2229/03/2315/05/2309/08/2314/11/2303/04/2420/05/24------

Upcoming sector events for BiomX Inc.

23/07/2024 VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
24/07/2024 BIOCON LIMITED: Q1 2025 Earnings Release (Projected)
25/07/2024 06:00 ARGENX SE: Q2 2024 Earnings Release
29/07/2024 RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected)
29/07/2024 CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SPRINGWORKS THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 XENCOR, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 SAREPTA THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
More events

Past sector events for BiomX Inc.

05/06/2024 08:51 PHARMAESSENTIA CORPORATION: May 2024 Sales and Revenue Release
17/05/2024 12:00 AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release
16/05/2024 12:46 BIOCON LIMITED: Q4 2024 Earnings Release
16/05/2024 06:00 ZEALAND PHARMA A/S: Q1 2024 Earnings Release
15/05/2024 LIGACHEM BIOSCIENCES INC.: Q1 2024 Earnings Release
15/05/2024 13:05 THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release
15/05/2024 12:00 CABALETTA BIO, INC.: Q1 2024 Earnings Release
14/05/2024 TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release
14/05/2024 21:05 ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release
14/05/2024 21:00 ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. PHGE Stock
  4. PHGE.U Stock
  5. Calendar BiomX Inc.